text_1: Cost effectiveness evaluations based on cRCT data accurately reflect prices for patients in actual clinical practice.
text_2: The mean cost of preventing one upper GI event as recorded in GPRD was US$104k (ranging from US$64k with long-term daily use to US$182k with intermittent use) and US$298k for hospitalizations.